Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study
- Erika P. Hamilton
- , Virginia Kaklamani
- , Carla Falkson
- , Gregory A. Vidal
- , Patrick J. Ward
- , Monika Patre
- , Stephen Y. Chui
- , Jacob Rotmensch
- , Kushagra Gupta
- , Luciana Molinero
- , Yijin Li
- , Leisha A. Emens
Research output: Contribution to journal › Article › peer-review
36
Link opens in a new tab
Scopus
citations